Freshfields and Liberty represented América Móvil on the deal. Baker Botts, Carey, Covington & Burling and FerradaNehme advised Liberty Latin America (LLA) América Móvil formed a...
América Móvil’s Joint Venture With Liberty Latin America In Chile
Cable & Wireless Panama’s Acquisition Of Claro Panama From América Móvil
Freshfields and Galindo, Arias y López represented América Móvil on the deal while Baker Botts and Alemán Cordero & Galindo Lee – Alcogal advised Liberty Latin...
Cargill, Incorporated and Consortium’s Take-Private Transaction Of Sanderson Farms
Freshfields represented both the buyer consortium and Cargill, Incorporated on the deal. Paul, Weiss advised Continental Grain. The transaction involved the take-private of Nasdaq-listed Sanderson Farms and...
Goldman Sachs Group’s €1.7 Billion Acquisition of NN Investment Partners
De Brauw advised NN Group on the deal. Freshfields represented The Goldman Sachs Group. NN Group completed the sale of its asset manager NN Investment Partners...
Goldfinch Partners and Baupost Group’s $910 Million Acquisition Of Western Union Business Solutions
Freshfields represented Western Union on the deal, while Skadden and Khaitan & Co represented Baupost Group and Goldfinch Partners. Western Union, the global leader in cross-border,...
Sitel Group’s $2.2 Billion Take-Private of Sykes Enterprises
Freshfields represented Sitel Group on the deal. Shumaker, Loop & Kendrick, LLP acted as legal advisor to Sykes Enterprises. Sitel Group®, a leading global provider of...
Siemens’ $700 Million Acquisition of Supplyframe
Freshfields Bruckhaus Deringer LLP advised Siemens on the deal. Siemens acquired Supplyframe, a leading Design-to-Source platform for the global electronics value chain, valued at $700 million. ...
Zymergen Inc.’s $4 Billion Initial Public Offering
Freshfields served as issuer’s counsel to Zymergen Inc. The IPO values the company in excess of $4 billion. The company sold $575 million of shares of...
Agilent’s Acquisition Of Resolution Bioscience
Freshfields advised Agilent (NYSE: A) on its acquisition of Resolution Bioscience. The combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with...